These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 33382962

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mass screening for neuroblastoma in Miyagi Prefecture.
    Itano M, Morita S, Fujie H, Ohashi Y, Minegishi N, Minegishi M, Yamaguchi Y, Sato T, Tsuchiya S, Konno T.
    Tohoku J Exp Med; 1992 Oct; 168(2):137-9. PubMed ID: 1306297
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Measurement of urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) for diagnosis of neural crest tumors.
    Sawada T.
    Pediatr Hematol Oncol; 1997 Oct; 14(4):291-3. PubMed ID: 9211532
    [No Abstract] [Full Text] [Related]

  • 5. Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography for mass screening of neuroblastoma.
    Sato Y, Hanai J, Takasugi N, Takeda T.
    Tohoku J Exp Med; 1986 Oct; 150(2):169-74. PubMed ID: 3810642
    [Abstract] [Full Text] [Related]

  • 6. Screening for neuroblastoma and age-specific incidence.
    Moe PJ.
    Acta Paediatr; 1999 Apr; 88(4):362-4. PubMed ID: 10342530
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analytical validation and clinical application of urinary vanillylmandelic acid and homovanillic acid by LC-MS/MS for diagnosis of neuroblastoma.
    Shen Y, Li H, Lu J, Luo X, Guan Q, Cheng L.
    Biomed Chromatogr; 2019 Jun; 33(6):e4484. PubMed ID: 30632178
    [Abstract] [Full Text] [Related]

  • 10. Feasibility study for neonatal neuroblastoma screening in the United States.
    Tuchman M, Fisher EJ, Heisel MA, Woods WG.
    Med Pediatr Oncol; 1989 Jun; 17(4):258-64. PubMed ID: 2747596
    [Abstract] [Full Text] [Related]

  • 11. Which cases are found and missed by neuroblastoma screening at 1 year? Results from the 1992 to 1995 study in three Federal States of Germany.
    Berthold F, Baillot A, Hero B, Schurr P, Nerenz A, Hunneman DH, Sander J.
    J Clin Oncol; 1999 Apr; 17(4):1200. PubMed ID: 10561179
    [Abstract] [Full Text] [Related]

  • 12. Method of measurement of urinary homovanillic acid and vanillylmandelic acid by gas chromatography-mass spectrometry suitable for neuroblastoma screening.
    Seviour JA, McGill AC, Dale G, Craft AW.
    J Chromatogr; 1988 Nov 18; 432():273-7. PubMed ID: 3220894
    [No Abstract] [Full Text] [Related]

  • 13. Mass screening for neuroblastoma in Japan.
    Sawada T, Sugimoto T, Kawakatsu H, Matsumura T, Matsuda Y.
    Pediatr Hematol Oncol; 1991 Nov 18; 8(2):93-109. PubMed ID: 1863547
    [Abstract] [Full Text] [Related]

  • 14. A simple coloured-paper thin-layer chromatography test as a backup procedure for vanillylmandelic acid and homovanillic acid evaluation in a neuroblastoma screening program.
    Mathieu P, Philip T, Greffe J, Montegue A, Lacroix C.
    Clin Chim Acta; 1993 Nov 15; 220(2):229-32. PubMed ID: 8111967
    [No Abstract] [Full Text] [Related]

  • 15. Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-old.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
    Jpn J Clin Oncol; 1986 Dec 15; 16(4):351-5. PubMed ID: 3795531
    [Abstract] [Full Text] [Related]

  • 16. Can mass screening for neuroblastoma detect patients with low vanillylmandelic acid and high homovanillic acid?
    Nishi M, Miyake H, Takeda T, Takasugi N, Hanai J, Kawai T.
    Acta Paediatr Jpn; 1989 Dec 15; 31(6):742-4. PubMed ID: 2516402
    [No Abstract] [Full Text] [Related]

  • 17. Urinary homovanillic and vanillylmandelic acid in the diagnosis of neuroblastoma: report from the Italian Cooperative Group for Neuroblastoma.
    Barco S, Gennai I, Reggiardo G, Galleni B, Barbagallo L, Maffia A, Viscardi E, De Leonardis F, Cecinati V, Sorrentino S, Garaventa A, Conte M, Cangemi G.
    Clin Biochem; 2014 Jun 15; 47(9):848-52. PubMed ID: 24769278
    [Abstract] [Full Text] [Related]

  • 18. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
    Cangemi G, Barco S, Reggiardo G, Viscardi E, Di Cataldo A, Garaventa A, Melioli G, Conte M.
    Pediatr Blood Cancer; 2013 Dec 15; 60(12):E170-2. PubMed ID: 23813598
    [Abstract] [Full Text] [Related]

  • 19. Results of mass screening for neuroblastoma in Sapporo, Japan.
    Takeda T, Nishi M, Shimada M, Nakadate H, Hatae Y, Naito H, Hanai J, Kawai T, Takasugi N.
    Prog Clin Biol Res; 1991 Dec 15; 366():595-601. PubMed ID: 2068178
    [No Abstract] [Full Text] [Related]

  • 20. Screening for neuroblastoma in North America--preliminary results from the Quebec project.
    Woods WG, Tuchman M, Lemieux B.
    Prog Clin Biol Res; 1991 Dec 15; 366():585-94. PubMed ID: 2068177
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.